NORTECH SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NORTECH SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $14.37M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $13.43M | Mar 31, 2025 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $118.37M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $128.13M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $139.33M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $134.12M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $115.17M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $104.11M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $116.33M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $113.37M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $112.34M | Apr 1, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $112.33M | Mar 27, 2018 |
| FY2017 | Dec 31, 2016 | $116.62M | Mar 27, 2018 |
| FY2016 | Dec 31, 2015 | $115.19M | Mar 8, 2017 |
| FY2015 | Dec 31, 2014 | $112.04M | Mar 22, 2016 |
| FY2014 | Dec 31, 2013 | $111.06M | Mar 11, 2015 |
| FY2013 | Dec 31, 2012 | $106.94M | Mar 7, 2014 |
| FY2012 | Dec 31, 2011 | $114.24M | Mar 8, 2013 |
| FY2011 | Dec 31, 2010 | $99.82M | Mar 9, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.01M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $16.72M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $23.10M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $20.48M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $15.86M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $9.67M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $12.58M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $13.31M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $12.12M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $13.84M | Mar 27, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($252.0K) | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($1.30M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $6.87M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.01M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $7.15M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($1.55M) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | ($1.23M) | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $166.0K | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | ($2.45M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $43.8K | Mar 27, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $975.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($195.0K) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $5.95M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $3.89M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $2.27M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($616.0K) | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $224.0K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $1.25M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | ($1.27M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $629.1K | Mar 27, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.17M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $1.19M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $1.20M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.46M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $483.0K | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 17, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.74M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | ($2.25M) | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $1.77M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $5.40M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | ($4.54M) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.36M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $997.0K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $2.44M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $806.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.53M | Mar 27, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $661.0K | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $1.27M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $1.28M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.37M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $1.29M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $485.0K | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $719.0K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $1.40M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $813.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.96M | Mar 27, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.92M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $72.44M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $75.13M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $69.54M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $67.09M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $57.63M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $61.41M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $59.96M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $52.09M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $55.52M | Mar 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.37M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $38.43M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $39.78M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $41.46M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $40.98M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $38.92M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $41.43M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $38.87M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $32.26M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $33.20M | Mar 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.55M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $34.01M | Apr 15, 2026 |
| FY2025 | Dec 31, 2023 | $35.34M | Apr 15, 2026 |
| FY2024 | Dec 31, 2022 | $28.08M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | $26.11M | Mar 20, 2024 |
| FY2022 | Dec 31, 2020 | $18.72M | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | $19.98M | Mar 17, 2022 |
| FY2020 | Dec 31, 2018 | $21.09M | Mar 23, 2021 |
| FY2019 | Dec 31, 2017 | $19.83M | Mar 19, 2020 |
| FY2018 | Dec 31, 2016 | $22.32M | Apr 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2019 | $2.38M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $2.38M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $2.38M | Apr 1, 2019 |
| FY2018 | Dec 31, 2016 | $3.28M | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $3.28M | Mar 27, 2018 |
| FY2015 | Dec 31, 2014 | $75.0K | Mar 22, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.12M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | $17.38M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | $18.67M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $11.83M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $9.82M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $2.66M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $4.21M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $5.44M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $3.89M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $6.34M | Mar 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.66M | Apr 15, 2026 |
| FY2024 | Dec 31, 2024 | $916.0K | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $960.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.03M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | $643.0K | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $352.0K | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $351.0K | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $480.0K | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $473.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $268.2K | Mar 27, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2020 | $7.07M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | $3.62M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | $4.40M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | $5.36M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $6.46M | Mar 27, 2018 |
| FY2016 | Dec 31, 2015 | $7.64M | Mar 8, 2017 |
| FY2015 | Dec 31, 2014 | $4.81M | Mar 22, 2016 |
| FY2014 | Dec 31, 2013 | $4.88M | Mar 11, 2015 |
| FY2013 | Dec 31, 2012 | $1.09M | Mar 7, 2014 |
| FY2012 | Dec 31, 2011 | $2.12M | Mar 8, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 2 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | 2 | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 27, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 2 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | 2 | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 27, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.79M | Apr 15, 2026 |
| FY2025 | Dec 31, 2024 | 2.76M | Apr 15, 2026 |
| FY2024 | Dec 31, 2023 | 2.74M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 2.67M | Mar 20, 2024 |
| FY2022 | Dec 31, 2021 | 2.67M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | 2.66M | Mar 17, 2022 |
| FY2020 | Dec 31, 2019 | 2.66M | Mar 23, 2021 |
| FY2019 | Dec 31, 2018 | 2.74M | Mar 19, 2020 |
| FY2018 | Dec 31, 2017 | 2.74M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 2.75M | Mar 27, 2018 |